User profiles for Ivan O. Rosas
 | Ivan O. RosasProfessor of Medicine, Baylor College of Medicine Verified email at bcm.edu Cited by 19342 |
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
[HTML][HTML] Tocilizumab in hospitalized patients with severe Covid-19 pneumonia
IO Rosas, N Bräu, M Waters, RC Go… - … England Journal of …, 2021 - Mass Medical Soc
Background Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation
and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a …
and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a …
Pathogenic mechanisms underlying idiopathic pulmonary fibrosis
The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of cell
types and signaling pathways. Recurrent alveolar epithelial cell (AEC) injury may occur in …
types and signaling pathways. Recurrent alveolar epithelial cell (AEC) injury may occur in …
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
We provide a single-cell atlas of idiopathic pulmonary fibrosis (IPF), a fatal interstitial lung
disease, by profiling 312,928 cells from 32 IPF, 28 smoker and nonsmoker controls, and 18 …
disease, by profiling 312,928 cells from 32 IPF, 28 smoker and nonsmoker controls, and 18 …
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
…, TR Ramalingam, BR Gochuico, IO Rosas… - Journal of Experimental …, 2010 - rupress.org
Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic
options. To better understand the inflammatory responses that precede and concur with …
options. To better understand the inflammatory responses that precede and concur with …
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
…, TH Sisson, JC Horowitz, IO Rosas… - … Journal of …, 2015 - journals.physiology.org
Pathological fibrosis is driven by a feedback loop in which the fibrotic extracellular matrix is
both a cause and consequence of fibroblast activation. However, the molecular mechanisms …
both a cause and consequence of fibroblast activation. However, the molecular mechanisms …
[HTML][HTML] MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis
Background Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic lung disease
associated with substantial morbidity and mortality. The objective of this study was to …
associated with substantial morbidity and mortality. The objective of this study was to …
[HTML][HTML] Lung volumes and emphysema in smokers with interstitial lung abnormalities
…, EK Silverman, H Hatabu, IO Rosas - … England Journal of …, 2011 - Mass Medical Soc
Background Cigarette smoking is associated with emphysema and radiographic interstitial
lung abnormalities. The degree to which interstitial lung abnormalities are associated with …
lung abnormalities. The degree to which interstitial lung abnormalities are associated with …
Progressive preclinical interstitial lung disease in rheumatoid arthritis
Background Early detection and treatment for interstitial lung disease (ILD) in patients with
rheumatoid arthritis (RA) may ameliorate disease progression. The objective of this study was …
rheumatoid arthritis (RA) may ameliorate disease progression. The objective of this study was …
[HTML][HTML] Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation
Background Mitochondrial DNA (mtDNA) is a critical activator of inflammation and the innate
immune system. However, mtDNA level has not been tested for its role as a biomarker in …
immune system. However, mtDNA level has not been tested for its role as a biomarker in …
